The principal sponsor of Partition Studies Quarterly is IBPS Consulting, a scientific and technical consulting firm specializing in CMC, non-clinical and clinical development, and regulatory and quality assurance services for the biopharma and pharmaceutical sectors.

IBPS Consulting’s focus is on biologics/biosimilars, vaccines, generics, differentiated products, and medical devices. The firm also provides go-to-market strategies and investor due-diligence support. It has a global footprint and was recently awarded for with a Top 50 Healthcare Companies Award for 2019 by the International Forum on Advancements in Healthcare.